Prostanoid DP1 receptor as a target for respiratory diseases

K. Metters, G. O‘Neill, T. R. Jones (Dorval, Canada)

Source: Annual Congress 2005 - New perspectives in asthma treatment
Session: New perspectives in asthma treatment
Session type: Poster Discussion
Number: 1388
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Metters, G. O‘Neill, T. R. Jones (Dorval, Canada). Prostanoid DP1 receptor as a target for respiratory diseases. Eur Respir J 2005; 26: Suppl. 49, 1388

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prostaglandin D2 and the role of the DP1, DP2 and TP receptors in the control of airway reflex events
Source: Eur Respir J 2015; 45: 1108-1118
Year: 2015



Toll-like receptors in lung diseases
Source: Annual Congress 2004 - Scientific year in review
Year: 2004

Down-regulation of allergic reactions by stimulation of prostaglandin E receptor EP3 subtype
Source: Annual Congress 2004 - Insights into asthma and COPD
Year: 2004


Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation
Source: ERJ Open Res, 6 (3) 00121-2020; 10.1183/23120541.00121-2020
Year: 2020



The pathway to inflammation in asthma: the role of the DP2 receptor
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

CS-003, a novel triple neurokinin receptor antagonist, inhibits symptoms of respiratory diseases models in guinea pigs
Source: Eur Respir J 2006; 28: Suppl. 50, 664s
Year: 2006

Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2 in the airway structural cells
Source: Eur Respir J 2005; 26: Suppl. 49, 346s
Year: 2005

Upregulation of cysteinyl leukotriene receptors CysLT1 and CysLT2 by TGF-β1 and LTE4 on human bronchial epithelial cells
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006


Effects of a newly developed dual CysLT1 and CysLT2 receptor antagonist, ONO-RS-531, on antigen- and leukotriene D4-induced contractions of isolated human bronchi
Source: Eur Respir J 2005; 26: Suppl. 49, 214s
Year: 2005

Toll-like receptors in COPD
Source: Eur Respir J, 49 (5) 1700739; 10.1183/13993003.00739-2017
Year: 2017



EP2 & EP4 receptor agonists inhibit the airway sensory nerves that cause cough, a potential protective control that is lost in human smokers and a pre-clinical COPD model
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017



Nicotinic alpha-7 receptor stimulation (a7nAChR) inhibited NF-kB/STAT3/SOCS3 pathways in a murine model of asthma.
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017



Modulation of cortical and respiratory activity by 5-HT2 receptor agonist in the rat
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008

Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes via stimulation of different 5-HT receptor subtypes
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005


Muscarinic receptors mediate up-regulation of endothelin-1 expression in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010